News

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the first quarter of fiscal year 2022. John Rim, CEO of Samsung Biologics, stated, “Samsung Biologics’ strong start to the 2022 fiscal year was driven...

The data is undeniable: COVID-19 instances and hospitalizations are on the rise in the United States, despite patchy documentation. Most states are witnessing an upsurge, with Washington, Georgia, Mississippi, South Dakota, Nevada, Maine, Hawaii, and Montana seeing more than a 50% rise...

Pfizer officials stated on an earnings call that while Paxlovid's first-quarter sales may seem to be low, there will be plenty more revenues in the next three months. Paxlovid, Big Pharma's COVID-19 oral antiviral, may soon benefit from agreements in...

Austedo, Teva's tardive dyskinesia (TD) therapy, has great prospects. Now the company only needs to worry about one less generic pharmaceutical presenting a threat to its main growth engine.Teva announced recently that it had reached an agreement with Lupin that...

According to updated information from the US Centers for Disease Control and Prevention, about 60% of adults plus 75% of children have antibodies suggesting that they've been exposed to COVID-19. The information comes from a long-term examination of blood...

Bristol Myers Squibb has gained approval for one of the year's most anticipated medications, following a brief delay in November. Camzyos, a drug developed by Bristol Myers Squibb, was approved by the FDA to cure symptomatic obstructive hypertrophic cardiomyopathy,...

Specialist Merseyside manufacturing business ChargePoint Technology is set to appear in an ITN production exploring its role in helping to bring the first COVID-19 vaccine to market. The company will feature in the upcoming programme “How Vaccines Are Changing The...